A New Mount Sinai Partnership With the U.S. Military Gets Underway

From the ranks of the U.S. military to the Icahn School of Medicine at Mount Sinai, from left: Ray Tang, Chris Bellaire, Brendan Bechard, and Thomas Fetherston.

A new Icahn School of Medicine at Mount Sinai admissions program for United States military personnel recently welcomed its first recruit: former Marine Lieutenant Chris Bellaire, who will join the Class of 2023 in September.

“The opportunity to apply when I was on active duty and then defer acceptance was so accommodating that it, honestly, changed my life,” says Mr. Bellaire, a Princeton University alumnus and former intelligence officer who supported Marine units engaged in tactical and special operations. Accepted to Mount Sinai’s program in March, he is currently attending a post-baccalaureate graduate program at Columbia University.

Chris Bellaire

All full-time active duty military personnel are eligible to apply to Mount Sinai if they have a baccalaureate degree from a U.S. or Canadian-accredited institution that is recognized by the U.S. Department of Education. The arrangement is similar to the Icahn School of Medicine’s popular FlexMed program, which allows college sophomores to apply for early assurance of acceptance to medical school. Students accepted through both FlexMed and the new military program do not take the Medical College Acceptance Test (MCAT).

Adjusting admissions requirements is rooted in evidence that students with “nontraditional” backgrounds match the performance of students who spend their college education immersed in science courses. Before taking their places in medical school, these aspiring physicians must complete one year of coursework in both biology and chemistry, a semester of physics, a semester of statistics, and one year of laboratory work in biology and/or chemistry. Admitted students are required to achieve a “B” in all required courses, and to maintain a cumulative GPA of 3.5. They must also log 100 hours of documented clinical service in nursing homes, clinics, or other patient facilities.

Military backgrounds enrich the pool of doctors, says David Muller, MD, Dean for Medical Education and the Marietta and Charles C. Morchand Chair in Medical Education at the Icahn School of Medicine at Mount Sinai. Medicine and service are inseparable, and service is paramount for women and men who are on active duty. “Through great efforts they give more than most of us can ever imagine giving in a lifetime,” Dr. Muller says. “They bring incredible talent, diverse knowledge, and unique skills to the learning environment and the health care workforce.”

Active duty often requires urgent decisions to be made under pressure, experience that is immensely valuable to doctors who work in emergency rooms, intensive care units, or operating rooms. “When you think about leadership, team building, discipline, maturity, and focus,” Dr. Muller says, “they embody the best of those attributes.”

Ray Tang

Indeed, second-year Mount Sinai medical student Ray Tang says his experience as an infantryman in the Marines, serving two deployments in Afghanistan in 2011 and 2013, provided him with the “strict discipline and organization that has helped me stay on top of my schoolwork, while maintaining good health and work-life balance. The training and deployments improved my mental toughness and ability to stay calm in stressful, high-risk situations,” he says. In addition, the teamwork he experienced in the Marines has helped him work effectively with others, which is a critical component of delivering excellent patient care.

Reaching prospective students with news of Mount Sinai’s tailored admissions process for applicants on active duty has been somewhat challenging, says Dr. Muller. But it was his 2015 interview with National Public Radio about nontraditional paths to a medical education that actually caught the attention of Mr. Bellaire. “I thought the door to medical school had closed. Then I heard about a school that values nontraditional experience,” he recalls. A phone call to express his interest in Mount Sinai’s medical school reached Dr. Muller, who told him about the new initiative. Mr. Bellaire applied in the fall of 2017 and had an interview at Mount Sinai in March 2018, one week after completing his military service.

During his stint in the Marines, and on his own time, Mr. Bellaire assisted in the emergency department and the intensive care unit of a hospital near the Marine Corps Base in Hawaii. While deployed in the Philippines, he confirmed his interest in global health and serving disenfranchised and vulnerable populations.

Seeing veterans with injuries and post-traumatic stress disorder helped spark Mr. Bellaire’s interest in medicine and steered him toward the Icahn School of Medicine’s Neuropathology Research Division Training Program, directed by John F. Crary, MD, PhD. While enrolled at Columbia, Mr. Bellaire is volunteering at Dr. Crary’s brain bank at Mount Sinai and learning about brain diseases in preparation for medical school next year.

Thomas Fetherston

Former infantry medic Thomas Fetherston, a first-year medical student and recipient of the F. Edward Hébert Armed Forces Health Professions Scholarship Program, approaches a career in medicine informed by his battlefield experience assisting injured soldiers in Afghanistan. The alarming frequency of suicide and suicidal thoughts among returning veterans has spurred his current interest in the use of ketamine for drug-resistant depression.

“Dealing with people who have suffered losses has enabled me to better understand their stress and to understand the doctors who are at the end of the line for a lot of their patients,” he says. After medical school and residency, he plans to resume his army career.

Now a second-year Mount Sinai medical student, Brendan Bechard enlisted in the Marines in 2005. While stationed in Quantico, Virginia, and Okinawa, Japan, he maintained the military’s vital supply chain and enhanced unit readiness for operations throughout Southeast Asia. When his service ended, he earned a bachelor’s degree in neuroscience from Columbia University and subsequently performed research for the Traumatic Stress Studies Division, which is directed by Rachel Yehuda, PhD, Professor of Psychiatry, and Neuroscience, at the Icahn School of Medicine at Mount Sinai and the James J. Peters VA Medical Center in the Bronx.

Brendan Bechard

“My interest in neuroscience is directly related to my service,” says Mr. Bechard, who leads the Icahn School of Medicine’s student group for military veterans. “It’s our duty as medical student-veterans to continue serving our sisters and brothers in arms.” In addition to furnishing a robust support community for all military veterans who work or study at the Mount Sinai Health System, the group encourages medical students to work with Veterans Affairs medical facilities in New York City.

Mount Sinai’s support for veterans has been incredibly encouraging, says Mr. Bellaire. “The new pathway program is an example of how the school really values diversity and service. It seemed like the perfect fit for me as I planned for my medical education after the military.”

Nurses Salute Physicians Who Excel as Partners in Care

From left: Laura Stark, DNP, RN; Frances Cartwright, PhD, RN-BC; Tao Xu, MD; Gregory Serrao, MD; and Judah Sueker, MD.

Before an enthusiastic audience of faculty and staff, and family and friends, 13 physicians at The Mount Sinai Hospital were honored by nurse colleagues and Nursing leadership with the 31st Annual Physician of the Year Award. The ceremony, held Tuesday, September 25, at Stern Auditorium, is a yearly salute to physicians who excel in patient care and foster strong collaborative partnerships with nurses.

“All of the award winners are partners in care and have earned the respect and appreciation of the Mount Sinai community of nurses,” said Frances Cartwright, PhD, RN-BC, Edgar M. Cullman, Sr. Chair of the Department of Nursing, and Chief Nursing Officer and Senior Vice President for Patient Care Services, The Mount Sinai Hospital.

Nurses showed their appreciation of the award winners with speeches, videos, and PowerPoint presentations, set to pop music and filled with accolades like these: excellent communicator, team player, compassionate, hands-on, forward-thinking, engaged, approachable, and thorough in patient care. Gregory Serrao, MD, who won the Fellow Award, thanked the nurses he works with at Mount Sinai Heart, saying, “They have become friends, they have become mentors, and they are living examples of what it means to always put patients first.

David L. Reich, MD, President and Chief Operating Officer, The Mount Sinai Hospital, said: “Every physician who was nominated by Mount Sinai nurses should feel a tremendous sense of pride for cultivating patient-care teams that promote clinical excellence.”

The 2018 honorees were:

House Officer Award

Judah Sueker, MD, Chief Resident, Department of Emergency Medicine

Fellow Award

Gregory Serrao, MD, Mount Sinai Heart

Attending Award

Tao Xu, MD, Assistant Professor of Medicine (Hospital Medicine)

Special Recognition Award

TeamSTEPPS Stroke Team, Department of Neurology: Benjamin Brush, MD; Bradley Delman, MD; Gregory Fernandez, MD; Andy Jagoda, MD; Cappi Lay, MD; Peter Shearer, MD; Hazem Shoirah, MD; Paul Singh, MD, MPH; Laura Stein, MD; Judah Sueker, MD; Stanley Tuhrim, MD.

From left: Tara Roche, RN; Laura Stark, DNP, RN; Hazem Shoirah; MD; Danielle Wheelwright, RN; Cappi Lay, MD; Frances Cartwright, PhD, RN-BC; Laura Stein, MD; Stanley Tuhrim, MD; Bradley Delman, MD; Judah Sueker, MD; and Paul Singh, MD.

Albert Siu, MD, MSPH, Elected to the National Academy of Medicine

Albert Siu, MD, MSPH

Albert Siu, MD, MSPH, chair emeritus of the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai, has been elected to the National Academy of Medicine. This is considered one of the highest honors in health and medicine, and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

“Dr. Siu is an exceptional leader in health policy research and medicine,” says Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System. “His knowledge of aging and health care policy will be a tremendous asset to the National Academy of Medicine.”

After serving as the chair from 2003 to 2017 of the Brookdale Department of Geriatrics and Palliative Medicine, the nation’s first—and now largest—medical school department of geriatrics, Dr. Siu has dedicated himself full time to building and leading the nation’s most ambitious Hospital at Home program. Under Dr. Siu’s leadership, and with the support of an award from the Center for Medicare & Medicaid Innovation, the program has provided acute hospital-level care for nearly 800 patients who otherwise would have been treated in the hospital.

“The Hospital at Home program has made a huge improvement in patients’ lives,” says Dr. Charney. “Its clinical outcomes show measurable reductions in patient readmissions, emergency department visits, and transfers to skilled nursing facilities.”

The Academy provides independent, objective analysis and advice on health issues, and its members are elected through a selective process. With the election of Dr. Siu, Mount Sinai has 21 current faculty members in the Academy.

National Cancer Institute Leader Visits Mount Sinai

From left: Luis M. Isola, MD, Professor of Medicine (Hematology and Medical Oncology), and Pediatrics; Ramon Parsons, MD, PhD, Director, The Tisch Cancer Institute; Norman E. Sharpless, MD, Director, National Cancer Institute; and William Oh, MD, Deputy Director, The Tisch Cancer Institute, and Associate Director of Clinical & Translational Research for the Institute.

Aging is one of the greatest risk factors for developing cancer, which is most frequently diagnosed among people aged 65-74. But there are no simple explanations for the “multifaceted” science behind this connection, according to Norman E. Sharpless, MD, Director of the National Cancer Institute (NCI).

On Thursday, September 13, Dr. Sharpless addressed the topic in a seminar titled “The Dynamic Interplay between Cancer and Aging,” which he presented before a standing-room-only crowd in Davis Auditorium on The Mount Sinai Hospital campus. Dr. Sharpless has devoted much of his career to studying the connection between cancer and aging. Developing a better understanding of this relationship is particularly important, he said, because people over the age of 65 make up the fastest growing segment of the nation’s population.

Dr. Sharpless was invited to speak about his own research by The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, where he spent the earlier part of the day meeting with leaders of the Institute and medical school. He had lunch with postdoctoral fellows and students who work in Mount Sinai’s cancer-focused laboratories, and met with faculty and staff who oversee Mount Sinai’s Cancer Center Support Grant. The grant provides Mount Sinai with its NCI designation as one of an elite group of U.S. institutions committed to the research and treatment of cancer.

During the day’s meetings, Dr. Sharpless shared his vision for NCI programs and discussed trends in funding and cancer research. The Tisch Cancer Institute received its NCI designation for the fi rst time in 2015 and is preparing to renew the competitive grant in 2019. Since his appointment to the NCI in 2017, Dr. Sharpless has spent time visiting NCI-designated cancer centers around the country. On his recent trip to New York City, he also visited the Albert Einstein Cancer Center.

Commencement and Achievement at Phillips School of Nursing

From left: Iris Okang, Liane Xie, and Rena Pomrantz were among the first cohort to graduate from the Accelerated Bachelor of Science in Nursing program.

The Phillips School of Nursing at Mount Sinai Beth Israel welcomed the next generation of nurses to the profession in a joyous Commencement in August. The ceremony also marked another milestone—the first 27 students graduated from the school’s new Accelerated Bachelor of Science in Nursing Program (ABSN). In addition, Bachelor of Science in Nursing degrees were conferred on nine registered nurses.

“The accelerated entrance option responds to current health care needs and employment demands and enjoys great popularity among applicants,” said Todd F. Ambrosia, DNP, MSN, FNAP, Dean of the Phillips School of Nursing. “Interest in our ABSN program has greatly exceeded our expectations.”

Lynne D. Richardson, MD, Professor of Emergency Medicine, and Population Health Science and Policy, and Vice Chair for Academic, Research and Community Programs at the Icahn School of Medicine at Mount Sinai, gave an inspiring keynote address. “I’ve been in health care for almost 40 years, and I have never regretted my decision to make taking care of patients an everyday part of my life,” Dr. Richardson said. “There is nothing you can choose to do that could bring you more satisfaction.”

It has been a year of achievement for the Phillips School of Nursing. In April, its Associate of Applied Science in Nursing Program was recertified by the Accreditation Commission for Education in Nursing through 2025, the maximum seven-year period. And in July, the school received its second consecutive four year designation as a Center of Excellence in Nursing Education™ by the National League of Nursing in the category of “Enhancing Student Learning and Professional Development.”

“New Heights” of Achievement Marked at Convocation

Dennis S. Charney, MD, delivered the State of the School Address.

A sense of accomplishment pervaded the 2018 Convocation Ceremony, which honored 13 renowned faculty members and celebrated the 50th anniversary of the Icahn School of Medicine at Mount Sinai. The event, held on Thursday, October 4, marked the beginning of the academic year and featured the annual State of the School Address by Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System.

“We are reaching new heights,” Dr. Charney said as he welcomed the honorees, their families and friends, faculty, staff , and Mount Sinai benefactors who filled Goldwurm Auditorium. “We have never had more endowed chairs than we are awarding tonight, which I think speaks for the health of our medical school and our Health System.” The honorees received named professorships in fields including computational biology, genetics and genomic sciences, personalized medicine, palliative care, geriatrics, therapeutics discovery, ophthalmology, and neuroscience.

Among its many accomplishments, Dr. Charney said, the Icahn School of Medicine at Mount Sinai received $348.5 million in National Institutes of Health (NIH) funding in fiscal year 2018—a 9.4 percent increase over the prior year—ranking the school No. 12 in the nation. “We also rank No. 4 in research dollars per investigator, which means our individual faculty are among the best in the country,” Dr. Charney said, citing figures from the Association of American Medical Colleges.

The School of Medicine has the largest Graduate Medical Education program in the nation, with more than 2,500 residents and fellows. Its master’s and PhD programs are growing in size and quality, and Mount Sinai is launching a biomedical data science program, “which is consistent with our overall commitment to be one of the best places in the country, if not the world, in genomic and data science,” Dr. Charney said. The matriculating class of medical students has a median grade point average of 3.84 (out of 4.0), and the Flex Med admissions program helped make it a well-rounded group. “We are always looking to recruit students who represent the spectrum of talents in America,” he said, “whether they major in humanities or hard science or have experience in the military.”

Among other high points:

Mount Sinai Innovation Partners, which translates research findings into health care products and services, generated 211 patents, 144 inventions, and 53 new licenses and options for the use of research. In addition, the new i3 Asset Accelerator funded four start-up projects based on Mount Sinai research, with seven proposals now under review.

The Mount Sinai Doctors Faculty Practice—the largest in the nation—had 7.8 percent higher revenues compared with 2017, and the number of calls to its Access Center rose to 3.48 million in 2018 from 2.67 million in 2017.

Mount Sinai, for the second consecutive year, was ranked No. 1 by DiversityInc magazine among hospitals and health care systems in the nation for excellence in diversity management and best practices. In addition, the Patricia S. Levinson Center for Multicultural and Community Affairs marked its 20th anniversary.

The Office of Well-Being and Resilience, led by Jonathan A. Ripp, MD, MPH, Senior Associate Dean, was created to support the well-being of students, staff, and faculty.

Mount Sinai launched an online series of articles in partnership with Scientific American Custom Media that marks the 50th anniversary of the Icahn School of Medicine and takes a sweeping look at research and innovation fueling the next generation of treatments.

Looking ahead, Dr. Charney said, “Our guiding principles are to take advantage of the size and excellence of our Health System, to have unrivaled excellence in our medical and graduate education, and to anticipate new areas of research. We developed a strategic plan in 2017, and we are now implementing that plan in 2018.” The latest initiatives include renovation at 3 East 101st Street that will create a 45,000-square-foot facility for data science and technology. In a comprehensive capital campaign, the Mount Sinai Health System is seeking to raise $1.5 billion or more to fund projects, including a Life Science Center at 102nd Street and Madison Avenue.

Among its research priorities, the School of Medicine is advancing immunology by exploring therapies that target cancer, heart disease, diabetes, and brain disorders. It also is making a major investment in precision medicine. “This is a big initiative of the NIH,” Dr. Charney said, “and Mount Sinai will lead the way” with the advantages of a large and diverse patient population and expertise in genomics, big data, supercomputing, and bioinformatics.

Marta Filizola, PhD, left, the Sharon and Frederick Klingenstein/ Nathan Kase, MD Professor, and Dean of the Graduate School of Biomedical Sciences, with Terry A. Krulwich, PhD, a pioneering predecessor in both roles.

Dr. Charney took a moment to recognize a “legendary leader,” Terry A. Krulwich, PhD, Professor Emeritus of Pharmacological Sciences, and Dean of the Graduate School of Biomedical Sciences from 1981 to 2002—one of the first women in the nation to fill this role. Dr. Krulwich, who recently retired, was a mentor and role model, and a groundbreaking bacteriologist who was continuously funded by the NIH for 40 years. Dr. Charney thanked her for decades of service to Mount Sinai, and she was acknowledged with lasting applause.

“I think we can be very proud of what the School of Medicine has become in just 50 years,” said Peter W. May, Chairman, Boards of Trustees, Mount Sinai Health System. “It is one of the nation’s top medical schools, in which we are training bright, creative, and innovative doctors. But we are also engaged in great medical research that generates new insights, diagnostics, and treatments.”

Kenneth L. Davis, MD, President and Chief Executive Officer, Mount Sinai Health System, noted these achievements and also urged the honorees to keep in sight the school’s core values, such as putting patients first, serving everyone who needs care regardless of their ability to pay, collaborating in the lab, and making discoveries that improve the lives of patients. “Fifty years ago, when I came to Mount Sinai as a medical student, I came to be a physician-scientist,” Dr. Davis said. “But the longer I have been here, the more I realized that my job was not just writing papers. It was not just getting millions of dollars in grants. It was about what would be left behind, what was lasting. My job was to be a steward of this institution—of its legacy and its heritage. That was my responsibility, and now it is yours.”

The Convocation Honorees

Front row, from left: Amy S. Kelley, MD, MSHS; Jian Jin, PhD; Ethylin Wang Jabs, MD; Marta Filizola, PhD; Kenneth S. Boockvar, MD, MS; Schahram Akbarian, MD, PhD; and Dennis S. Charney, MD. Back row, from left: Paul A. Slesinger, PhD; Eric Schadt, PhD; Rachel Saunders-Pullman, MD, MPH, MS; Richard B. Rosen, MD; Adam A. Margolin, PhD; Ruth Loos, PhD; Andrew B. Leibowitz, MD; and Peter W. May.

Schahram Akbarian, MD, PhD, Mount Sinai Professor in Psychiatric Epigenomics

Kenneth S. Boockvar, MD, MS, Anna A. Greenwall Professor of Geriatrics and Adult Development

Marta Filizola, PhDSharon and Frederick Klingenstein/Nathan Kase, MD Professorship

Ethylin Wang Jabs, MDMount Sinai Professor in Developmental Genetics

Jian Jin, PhDMount Sinai Professor in Therapeutics Discovery

Amy S. Kelley, MD, MSHSHermann Merkin Professor in Palliative Care

Andrew B. Leibowitz, MDMount Sinai Professor in Perioperative Care

Ruth Loos, PhDCharles Bronfman Professor in Personalized Medicine

Adam A. Margolin, PhDJean C. and James W. Crystal Professor of Genetics and Genomic Sciences

Richard B. Rosen, MDBelinda Bingham Pierce and Gerald G. Pierce, MD Distinguished Chair of Ophthalmology

Rachel Saunders-Pullman, MD, MPH, MSBachmann-Strauss Professor

Eric Schadt, PhDMount Sinai Professor in Predictive Health and Computational Biology

Paul A. Slesinger, PhDLillian and Henry M. Stratton Professor of Neuroscience

Pin It on Pinterest